Use of recombinant human erythropoietin to treat the anemia of myelodysplastic syndromes.
Greenberg
P L
PL
Department of Medicine, Stanford University School of Medicine, CA.
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000150:complications*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D004921:Erythropoietin